ARIO PHARMA LIMITED

Dissolved Cambridge

Research and experimental development on biotechnology

Life sciences and medical technology Research and experimental development on biotechnology
A

ARIO PHARMA LIMITED

Research and experimental development on biotechnology

Founded 29 Sept 2010 Dissolved Cambridge, United Kingdom website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

PROVESICA LIMITED 29 Sept 2010 — 17 Sept 2013
Accounts Submitted 25 Mar 2019
Confirmation Submitted 30 Sept 2019 Next due 13 Oct 2020 69 months overdue
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

Pem Salisbury House Station Road Cambridge CB1 2LA

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ARIO PHARMA LIMITED (07391909), a dissolved life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 29 Sept 2010. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 4,680,434 Shares £262057.52m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Feb 2017200,000£200k£1
12 Mar 2015275,884£263k£0.954
28 Jan 2014607,911£6k£0.01
30 Oct 20131,048,218£1000k£0.954
23 Sept 2013943,396£900k£0.954

Officers

Officers

1 active 2 resigned
Status
Geert-jan MulderDirectorDutchNetherlands5915 Dec 2010Active

Shareholders

Shareholders (104)

Forbion Coinvestment Co-operatief Ua
36.5%
4,254,019
The Seroba Kernel Life Sciences Ii Fund Lp
14.8%
1,725,192

Persons with Significant Control

Persons with Significant Control (1)

1 Active

John William Ford

British

Active
Notified 6 Apr 2016
Residence England
DOB July 1974
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Sept 2021GazetteGazette Dissolved Liquidation
22 Jun 2021InsolvencyLiquidation Voluntary Members Return Of Final Meeting
10 Jun 2020AddressChange Registered Office Address Company With Date Old Address New Address
9 Jun 2020InsolvencyLiquidation Voluntary Appointment Of Liquidator
9 Jun 2020InsolvencyLiquidation Voluntary Declaration Of Solvency
22 Sept 2021 Gazette

Gazette Dissolved Liquidation

22 Jun 2021 Insolvency

Liquidation Voluntary Members Return Of Final Meeting

10 Jun 2020 Address

Change Registered Office Address Company With Date Old Address New Address

9 Jun 2020 Insolvency

Liquidation Voluntary Appointment Of Liquidator

9 Jun 2020 Insolvency

Liquidation Voluntary Declaration Of Solvency

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

4 years ago on 22 Sept 2021

Liquidation Voluntary Members Return Of Final Meeting

4 years ago on 22 Jun 2021

Change Registered Office Address Company With Date Old Address New Address

5 years ago on 10 Jun 2020

Liquidation Voluntary Appointment Of Liquidator

5 years ago on 9 Jun 2020

Liquidation Voluntary Declaration Of Solvency

5 years ago on 9 Jun 2020